Hilz et al., in 2019, also examined 715 breast cancer patients and 916 controls from Latvia, and they did not find any carriers with RECQ1 mutation c.1667_1667+3delAGTA in their case group, but they found 2 in their control group [72]. This evidence concerns the gene RECQL and breast carcinoma.